Synflex-M 85mg/500mg Tablets – Sumatriptan & Naproxen for Acute Migraine Relief

Drug Class: Triptan + NSAID Combination Anti-Migraine | Form: Oral Tablet | Prescription Status: Prescription Only (Rx)

What Is Synflex-M 85mg/500mg?

Synflex-M 85mg/500mg is a prescription fixed-dose combination tablet specifically formulated for the acute treatment of migraine headaches in adults — containing two active ingredients that target migraine through two completely different and complementary mechanisms simultaneously. Sumatriptan 85mg is a selective serotonin 5-HT1B/1D receptor agonist — a triptan that directly reverses the abnormal cranial blood vessel dilation and neurogenic inflammation that drive migraine pain. Naproxen Sodium 500mg is a potent NSAID that blocks prostaglandin synthesis — reducing the peripheral and central sensitisation that amplifies and sustains migraine pain. Together they attack the migraine process from two independent pharmacological angles at the same time — producing faster, more complete, and more sustained migraine relief than either medicine can achieve alone.

The rationale for combining a triptan with an NSAID in a single tablet is firmly evidence-based. Clinical trials have consistently demonstrated that Sumatriptan-Naproxen combination produces significantly better 2-hour pain freedom, sustained pain freedom at 24 hours, and lower migraine recurrence rates compared to either Sumatriptan alone or Naproxen alone at equivalent doses — addressing both the acute vascular-neurological component of migraine and the prolonged inflammatory sensitisation that causes migraine to recur and persist.

Synflex-M is a rescue treatment for individual acute migraine attacks — it is not a preventive medicine and should not be taken daily. It must be taken as early as possible at the onset of a migraine attack for best results.

What Is Synflex-M 85mg/500mg Used For?

Synflex-M 85mg/500mg is prescribed for:

• Acute migraine with aura (آدھے سر کا درد با اثرات) — migraine attacks preceded by neurological warning symptoms such as visual disturbances, zigzag lines, blind spots, tingling in face or hands, or speech difficulty before the headache phase
• Acute migraine without aura — migraine attacks presenting directly as moderate to severe unilateral throbbing headache with nausea, vomiting, and sensitivity to light and sound without preceding neurological symptoms
• Migraine with associated nausea and vomiting — Sumatriptan's vasoactive mechanism and Naproxen's anti-inflammatory effect together reduce both headache intensity and migraine-associated nausea
• Migraine with high recurrence — the Naproxen component specifically reduces migraine recurrence within 24 hours — a common limitation of triptan monotherapy — making Synflex-M particularly valuable for patients whose migraines recur after initial triptan relief

Synflex-M is for acute migraine treatment only — it is not effective as a migraine preventive medication and must not be taken daily. It should not be used for tension headache, cluster headache, or hemiplegic migraine.

How Does Synflex-M 85mg/500mg Work?

The clinical superiority of Synflex-M over single-agent migraine treatment lies in its simultaneous targeting of two distinct phases of the migraine process:

Sumatriptan 85mg — Selective 5-HT1B/1D Receptor Agonist (Triptan): Migraine involves abnormal dilation of cranial blood vessels — particularly the meningeal and dural vessels — triggered by a cascade of neurological events involving the trigeminovascular system. During a migraine attack, trigeminal nerve fibres release vasoactive neuropeptides — particularly CGRP (calcitonin gene-related peptide) and substance P — that cause cranial vasodilation and neurogenic dural inflammation, generating the throbbing, pulsating headache characteristic of migraine.

Sumatriptan selectively binds to 5-HT1B receptors on cranial blood vessel walls — causing vasoconstriction that directly reverses the pathological vasodilation driving migraine pain. Simultaneously, it binds to 5-HT1D receptors on trigeminal nerve terminals — inhibiting the release of CGRP, substance P, and other pro-inflammatory neuropeptides that sustain the neurogenic inflammation and central sensitisation of migraine. This dual vascular and neuronal action addresses the migraine attack at its primary neurobiological source — producing rapid and targeted anti-migraine effect that non-specific analgesics cannot replicate.

Naproxen Sodium 500mg — COX Inhibitor and Prostaglandin Suppressor: Prostaglandins — produced by COX-1 and COX-2 enzymes — are key mediators of the peripheral and central sensitisation that develops during a migraine attack. Peripheral sensitisation occurs when prostaglandins sensitise trigeminal pain fibres around meningeal blood vessels — lowering their activation threshold and amplifying pain signals. Central sensitisation develops as the prolonged barrage of pain signals progressively sensitises neurons in the trigeminal nucleus and thalamus — causing the throbbing quality, allodynia, and nausea that characterise fully established migraine.

By potently blocking COX enzymes and suppressing prostaglandin synthesis throughout both the peripheral and central nervous system, Naproxen Sodium 500mg reduces this sensitisation cascade — decreasing pain amplification, reducing nausea, and addressing the inflammatory component of migraine that Sumatriptan alone does not fully target. Critically, Naproxen's prolonged 12 to 17-hour half-life provides sustained anti-inflammatory and anti-sensitisation activity long after Sumatriptan's shorter plasma half-life has diminished — explaining why the combination produces significantly lower migraine recurrence rates at 24 hours compared to triptan monotherapy.

Combined Synergistic Effect: Sumatriptan addresses the acute vascular and neurogenic trigger of migraine — reversing cranial vasodilation and blocking neuropeptide release. Naproxen addresses the inflammatory sensitisation that amplifies and sustains migraine pain and drives recurrence. The two mechanisms are complementary and sequential — Sumatriptan acts first on the primary vascular-neurological event while Naproxen's sustained anti-inflammatory activity covers the prolonged sensitisation phase. Together they produce faster onset, greater headache relief at 2 hours, and significantly better sustained pain freedom at 24 hours than either component achieves alone.

Dosage and Administration

⚠️ Take as early as possible at the very first sign of a migraine headache — do not wait until pain is severe. Never take as a preventive medication. Do not use more than two tablets in 24 hours. Do not use on more than 10 days per month — frequent use causes medication overuse headache. Always take with food to protect the stomach from Naproxen's gastric effects.

Critical Dosing Rules:

• Take the first tablet at the very first sign of migraine headache — early treatment during mild pain produces significantly better outcomes than treatment once pain is severe and central sensitisation is fully established
• If the first tablet produces no response at all — a second tablet is unlikely to help in the same attack; seek medical advice
• If partial response — a second tablet may be taken after a minimum of 2 hours
• Never exceed 2 tablets in any 24-hour period
• Do not use Synflex-M on more than 10 days per month — frequent triptan or NSAID use causes medication overuse headache (MOH), a chronic daily headache syndrome that is difficult to treat

How to Take:

1. Swallow the tablet whole with a full glass of water
2. Take with food or after a meal — mandatory for every dose to protect the stomach from Naproxen's gastric effects
3. Take at the earliest possible moment after migraine headache begins — not during aura, and not by waiting until pain peaks
4. Rest in a quiet, darkened room after taking if possible — Synflex-M works best with reduced sensory stimulation during the treatment period
5. Do not drive if migraine or medication causes dizziness or visual disturbance

Active Ingredients

Who Should NOT Take Synflex-M 85mg/500mg?

Do not take Synflex-M if you:

• Have established coronary artery disease — including angina, history of heart attack, or coronary artery vasospasm (Prinzmetal's angina) — Sumatriptan's vasoconstrictive action can compromise coronary blood flow
• Have had a stroke or TIA — Sumatriptan is contraindicated in cerebrovascular disease
• Have uncontrolled hypertension — Sumatriptan causes transient blood pressure elevation through vasoconstriction
• Have peripheral vascular disease — Sumatriptan's vasoconstriction worsens arterial insufficiency
• Have severe liver or kidney impairment — both components require hepatic and renal metabolism and excretion
• Have hemiplegic or basilar migraine — triptans are contraindicated in these specific migraine subtypes involving neurological deficits
• Are taking MAO inhibitors or have taken them within 14 days — dangerous Sumatriptan interaction causing serotonin syndrome risk
• Are taking other triptans or ergotamine-containing medicines — never combine two vasoconstrictive anti-migraine agents within 24 hours
• Are taking SSRIs or SNRIs — serotonin syndrome risk with triptan combination; discuss with doctor before using
• Have an active stomach ulcer or gastrointestinal bleeding — Naproxen contraindicated
• Are in the third trimester of pregnancy — both Sumatriptan and NSAIDs carry significant foetal risks at this stage
• Are allergic to Sumatriptan, Naproxen, any other NSAID or triptan, or any ingredient in this product
• Are under 18 years of age — not approved for paediatric use

Always consult your doctor before use if you:

• Have cardiovascular risk factors — diabetes, hypertension, smoking, high cholesterol, obesity, strong family history — even without established disease
• Have mild to moderate kidney or liver impairment
• Have asthma — particularly aspirin or NSAID-sensitive asthma
• Are pregnant (first or second trimester) or breastfeeding
• Are over 65 years of age — higher cardiovascular and gastrointestinal NSAID risk

Side Effects

Common (Sumatriptan-related):

• Sensation of tingling, warmth, heaviness, pressure, or tightening in the chest, throat, neck, or jaw — very common triptan class effect; usually mild and transient but must be distinguished from cardiac chest pain
• Dizziness or lightheadedness
• Drowsiness or fatigue
• Flushing or feeling of warmth
• Nausea — may be migraine-related or medication-related

Common (Naproxen-related):

• Nausea or stomach discomfort — reduced by taking with food
• Heartburn or indigestion

Serious — Stop Use and Seek Emergency Medical Attention Immediately:

• Cardiac events — actual chest pain, tightening, or pressure with shortness of breath, sweating, arm or jaw pain — Sumatriptan's vasoconstrictive effect can in rare cases cause coronary vasospasm or ischaemia (یہ طبی ہنگامی صورتحال ہے)
• Serotonin syndrome — when combined with SSRIs, SNRIs, or MAOIs — agitation, confusion, rapid heart rate, high temperature, muscle rigidity, tremor (یہ طبی ہنگامی صورتحال ہے)
• Stroke symptoms — sudden severe headache, facial drooping, arm weakness, speech difficulty, vision loss — distinguish from migraine aura; seek emergency care immediately (یہ طبی ہنگامی صورتحال ہے)
• Severe allergic reaction — rash, swelling of face, lips, or throat, difficulty breathing (یہ طبی ہنگامی صورتحال ہے)
• Gastrointestinal bleeding — dark or black tarry stools, vomiting blood — from the Naproxen component
• Medication overuse headache (MOH) — using Synflex-M on more than 10 days per month transforms episodic migraine into a chronic daily headache pattern that is extremely difficult to reverse

Drug Interactions

Storage Instructions

• Store below 25°C in a cool, dry place
• Protect from moisture and direct sunlight
• Keep in original blister pack until use
• Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں)
• Do not use after the expiry date on the pack or carton

Frequently Asked Questions

Why does Synflex-M combine a triptan with Naproxen — why not just use a higher dose of Sumatriptan?

Simply increasing the Sumatriptan dose beyond 85mg does not proportionally improve migraine outcomes but does increase side effects including chest tightness, dizziness, and cardiovascular risk. The addition of Naproxen Sodium 500mg addresses a completely different and complementary aspect of the migraine process — the prostaglandin-mediated inflammatory sensitisation that Sumatriptan alone does not fully suppress. Clinical trials specifically comparing Sumatriptan-Naproxen combination against Sumatriptan alone demonstrated that the combination produces significantly better 2-hour pain freedom, better sustained relief at 24 hours, and dramatically lower migraine recurrence rates — because Naproxen's prolonged anti-inflammatory activity prevents the sensitisation rebound that allows migraine to return after initial triptan relief fades.

I feel chest tightness after taking Synflex-M — should I be concerned?

Chest tightness, pressure, or a heavy sensation in the chest, throat, or neck is a very commonly reported and well-recognised side effect of all triptans including Sumatriptan — occurring in up to 15% of patients. In the vast majority of cases, these sensations are not cardiac in origin but reflect Sumatriptan's vasoconstrictive effect on oesophageal smooth muscle and chest wall vessels. However, because Sumatriptan can in rare cases cause true coronary vasospasm in susceptible patients, it is essential to distinguish between the typical mild triptan chest sensation and genuine cardiac chest pain. If the chest discomfort is severe, is accompanied by shortness of breath, sweating, left arm or jaw pain, or feels different from any previous triptan-related sensation — stop the medication and seek emergency medical attention immediately. Inform your doctor about any chest sensations experienced with Synflex-M so your cardiovascular risk can be reassessed.

What is medication overuse headache — how does it relate to Synflex-M?

Medication overuse headache (MOH) — also called rebound headache — is a chronic daily headache condition caused by taking acute headache medicines too frequently. When triptans, NSAIDs, or combination products like Synflex-M are used on more than 10 days per month regularly, the brain adapts to the constant presence of these medicines by becoming hypersensitive to pain when they wear off — producing a headache that drives the patient to take more medication, creating a self-perpetuating cycle. MOH is notoriously difficult to treat — requiring complete withdrawal of the overused medication under medical supervision, which causes a temporary severe worsening of headache for 1 to 2 weeks before improvement begins. Preventing MOH requires strict adherence to the maximum 10 days per month usage rule for Synflex-M — patients with frequent migraines requiring more than 10 treatment days monthly should discuss preventive migraine therapy with their neurologist instead of escalating acute treatment frequency.

Can Synflex-M be taken during pregnancy?

Sumatriptan use in pregnancy — particularly the first and second trimesters — has been studied in pregnancy registries without definitive evidence of major teratogenic risk, though data is limited. The Naproxen component introduces more concern — NSAIDs are associated with reduced amniotic fluid, foetal renal effects after 20 weeks, and premature closure of the ductus arteriosus. In the third trimester, both components carry significant foetal risks and are contraindicated. For pregnant women suffering from acute migraine, Paracetamol remains the safest first-choice analgesic, with specialist neurological and obstetric input required before any triptan or NSAID is considered. Never self-medicate migraine with Synflex-M during pregnancy without explicit specialist guidance.

Can I take Synflex-M if I am already on an antidepressant like Sertraline or Fluoxetine?

This requires careful discussion with your doctor before using Synflex-M. SSRIs such as Sertraline and Fluoxetine increase serotonergic activity in the brain, and Sumatriptan also acts on serotonin receptors — in theory creating conditions for serotonin syndrome when combined. Regulatory bodies have issued warnings about this combination, though the absolute risk of serotonin syndrome with the Sumatriptan-SSRI combination appears low in clinical practice. Symptoms of serotonin syndrome — agitation, confusion, rapid heart rate, muscle rigidity, high temperature, and tremor — constitute a medical emergency. If you are on an SSRI or SNRI and require triptan therapy for migraines, your doctor will assess the individual risk-benefit balance and advise on monitoring for serotonin toxicity symptoms after each dose.

---

⚕️ Medical Disclaimer: This product description is for general informational purposes only and does not replace professional medical advice. Synflex-M is a prescription combination anti-migraine medication — always use under the supervision of a qualified doctor or neurologist. Do not use more than 10 days per month. Take with food. If you experience chest pain, stroke symptoms, or signs of serotonin syndrome after taking this medicine, seek emergency medical attention immediately.

---

Prescription Required (Rx) | Take at First Sign of Migraine — Not During Aura | Always Take With Food | Maximum 2 Tablets Per 24 Hours | Do Not Use More Than 10 Days Per Month — MOH Risk | Never Combine With Other Triptans or Ergotamine